Immune check points in cancer treatment: current challenges and perspectives
Br J Cancer
.
2023 Oct;129(9):1365-1366.
doi: 10.1038/s41416-023-02478-6.
Authors
Joseph Ciccolini
1
,
Gerard Milano
2
Affiliations
1
SMARTc COMPO, Inria Inserm U1068 Centre de Recherche en Cancérologie de Marseille, Marseille, France. ciccolini.joseph@gmail.com.
2
Centre Antoine Lacassagne, Nice, France.
PMID:
37898723
PMCID:
PMC10628071
(available on
2024-10-28
)
DOI:
10.1038/s41416-023-02478-6
No abstract available
Publication types
Editorial
MeSH terms
Humans
Neoplasms*
Programmed Cell Death 1 Receptor
Substances
Programmed Cell Death 1 Receptor